Meira, Bruna
Degos, Bertrand
Corsetti, Elise
Doulazmi, Mohamed
Berthelot, Emeline
Virbel-Fleischman, Clara http://orcid.org/0000-0002-3951-4653
Dodet, Pauline
Méneret, Aurélie
Mariani, Louise-Laure
Delorme, Cécile
Cormier-Dequaire, Florence
Bendetowicz, David http://orcid.org/0000-0002-6310-1250
Villain, Nicolas
Tarrano, Clément
Mantisi, Lise
Letrillart, Hélène
Louapre, Céline
McGovern, Eavan
Worbe, Yulia
Grabli, David
Vidailhet, Marie
Hainque, Elodie
Roze, Emmanuel http://orcid.org/0000-0001-9727-3459
Article History
Received: 9 November 2020
Accepted: 9 April 2021
First Online: 11 June 2021
Competing interests
: B.D. served on scientific advisory boards for Aguettant, received research support from Orkyn and Elivie, and received travel grant from Orkyn and Elivie; E.B. received travel grant from Vitalaire and PEPS; C.V.-F. received a grant from Association Nationale de la Recherche et de la Technologie and full-time employment by Air Liquide Healthcare; P.D. received a travel grant from UCB pharma; A.M. received travel funding from AbbVie and Merz; L.-L.M. received speech honoraria from Lundbeck and Teva and received travel funding from the Medtronic, Teva, and AbbVie; C.D. received travel grant from Medtronic and Boston Scientific; D.B. received travel grant from Boston Scientific; L.M. received a travel grant from Orkyn (Air Liquide), Abbvie, Elivie, and Medtronic; H.L. received a travel grant from Orkyn (Air Liquide), Abbvie, and Elivie; E.M. received travel grant from Elivie; D.G. served on scientific advisory boards for AbbVie and Zambon, received speech honoraria from Medtronic and Abbvie, received research support from Air Liquide, and received travel grant from Abbvie; E.H. served on scientific advisory boards for Medtronic and Boston Scientific, received honoraria for speeches from Boston Scientific, and received travel grant from Merz; E.R. served on scientific advisory boards for Orkyn and Aguettant, received honoraria for speeches from Orkyn, Aguettant, and EVER Pharma, received research support from Orkyn, Aguettant, Elivie, and EVER Pharma, and received travel grant from Vitalaire, PEPS development, Aguettant, Orkyn, Elivie, and Adelia Medical. B.M, E.C., M.D., F.C.D., N.V, C.T., C.L., Y.W., and M.V. declare absence of commercial or financial relationships that could be construed as potential conflicts of interest.